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Abstract
Background: Mowat-Wilson syndrome (MWS) is a genetic condition characterized by distinctive facial features,
moderate to severe intellectual disability, developmental delay and multiple congenital anomalies. MWS is caused
by heterozygous mutations or deletions of the ZEB2 gene located on chromosome 2q22.3. At present, over 190
cases with mutations and deletions involving the ZEB2 gene have been reported, but triplication or duplication of
reciprocal region of Mowat-Wilson syndrome has never been reported.
Case Presentation: Here we report a 2-year-2-month-old boy carrying a de novo 2.9 Mb complex copy number
gain at 2q22.3 involving triplication of ZEB2 gene. The boy is characterized by intrauterine growth retardation,
hypotonia, cognitive impairment, multiple congenital anomalies and behavioral abnormalities.
Conclusion: This case provides evidence that triplication of ZEB2 gene may be clinical significance and ZEB2 gene
is likely to be a dosage sensitive gene.
Keywords: Mowat-Wilson syndrome, Distinctive facial features, Intellectual disability, Developmental delay,
Congenital anomalies, Behavioral abnormalities, ZEB2-triplication
Background
Mowat-Wilson syndrome (MWS; OMIM# 235730) is an
autosomal dominant genetic syndrome with multiple con-
genital anomalies. MWS is characterized by distinctive
facial features, epilepsy, moderate to severe intellectual
disability, global developmental delay, and congenital
anomalies including agenesis of the corpus callosum,
Hirschsprung disease, genitourinary anomalies, hypospa-
dias, congenital heart disease, short stature and hypotonia
[1–6]. MWS individuals display behavior problems includ-
ing a happy affect and sociable demeanor, repetitive be-
haviors, pain insensitivity and a high rate of oral behaviors
[7]. Eye abnormalities and craniosynostosis are rare fea-
tures of this syndrome [8–10]. Eye abnormalities include
iris/retinal colobomas, atrophy or absence of the optic
nerve, hyphema, and deep refraction troubles, sometimes
leading to severe visual consequences [8]. The syndrome
is caused by heterozygous deletions or mutations of
ZEB2 (OMIM# 605802) gene located on chromosome
2q22.3. So far, more than 190 individuals with MWS
have been described, who result from more than 100
different mutations or deletions of ZEB2 gene. How-
ever, no obvious genotype-phenotype correlation was
observed unless MWS patients carrying large deletions
presented with more severe conditions, which may be
the effect of continuous genes deletion [11–14]. Cur-
rently, no clinical presentations of patients with ZEB2
copy number gain have been reported. Here, we report
the first case of a de novo 2.9 Mb copy number gain at
2q22.3 involving triplication of the entire ZEB2 gene
detected by chromosomal microarray analysis (CMA).
This case suggests that ZEB2 gene is likely to be a dos-
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Case presentation
The proband was the first child of healthy unrelated par-
ents and family history was unremarkable. Intrauterine
growth retardation was noticed by ultrasound examin-
ation at 7 months of pregnancy. He was born by vaginal
delivery at 38 weeks of gestation. Birth weight was
3.0 kg (20.3 %), length 48 cm (8.5 %) and head circum-
ference 32 cm (1.7 %). Apgar scores were all 9. He had
severe hypotonia. No feeding difficulty was noted at all
times. The development milestones were delayed: he
raised his head at 4 months of age, sat alone at 8 months
and walked without assistance at 1 year 8 months. Lan-
guage development was significantly delayed.
The patient was 2 years 2 months old at the time of mo-
lecular evaluation. His weight was 12.5 kg (39.7 %), height
86.2 cm (17.9 %) and head circumference 48.5 cm
(46.3 %). He demonstrated catch-up growth but hypotonia
persisted. His voice was low and he cried weakly. His re-
ceptive language was relative normal but he used body
language to communicate. His cognitive competence was
lower than his peers. On physical examination, his dis-
tinctive facial features included scaphocephaly, flat facial
profile, auricle dysplasia, low-set and asymmetrical ears,
small eyes, flat nose bridge, shallow philtrum, small
mouth, teeth dysplasia, micrognathia, sparse eyebrows
and hair. He had short hands and broad fingers (Fig. 1).
Echocardiography revealed a small atrial septal defect. No
genitourinary anomalies was noticed except for small tes-
tes. He had chronic and mild to moderate constipation,
but no intestinal blockage and enlargement of the colon,
and was not diagnosed with Hirschsprung disease. He al-
ways displayed a smiling, open-mouth expression and a
happy, sociable demeanor as well as timid behavior. He
never presented with epileptic seizures, and EEG was nor-
mal. The brain magnetic resonance imaging (MRI) showed
normal corpus callosum and no other brain structural ab-
normalities. No additional abnormalities was noticed.
Methods
Chromosomal microarray analysis
Chromosomal microarray analysis was performed for
the proband and both parents using Affymetrix Cytoscan
HD Array (Affymetrix, USA). Genomic DNA was ex-
tracted from peripheral blood using a commercial kit
(Qiagen). The labeling and hybridization procedures
were performed following manufacturer’s instructions.
The raw data of chromosomal microarray was analyzed
by Affymetrix Chromosome Analysis Suite Software.
Results
CMA test revealed a complex gain of copy number at
2q22.2q22.3, which involves a duplication (chr2:143,88
6,436-144,391,185) and a triplication (chr2:144,391,186-
146,831,592) (Fig. 2). Parental tests were normal. Thus,
the proband carried a de novo copy number variant.
Discussion
ZEB2 gene mutations or deletions cause Mowat-Wilson
syndrome through a haploinsufficiency mechanism, but
little is known about the clinical significance of ZEB2
copy number gain. In this study, we report a 2-year-2-
month-old boy with global developmental delay, cognitive
impairment, multiple congenital anomalies and behavior
problems who carried a de novo 2.9 Mb triplication at
2q22.3 involving the entire ZEB2, GTDC1 and TEX41
genes and part of ARHGAP15 gene. No other clinical
significant CNVs were detected. The patient’s clinical
presentation was compared with the typical features of
Mowat-Wilson syndrome (Table 1). Some of our patient’s
clinical features overlapped with that of Mowat-Wilson
syndrome, in particular, severe speech impairment with
relative preservation of receptive language, open-mouth
appearance and happy demeanor. However, his distinctive
facial features were significantly different from that of
MWS which included deep-set large and widely spaced
eyes, upturned earlobes, saddle nose with rounded nasal
tip, pointed chin, flaring eyebrows and elongated face. He
had significant intrauterine growth retardation and severe
hypotonia whereas he demonstrated postnatal catch-up
growth but hypotonia persisted. No triplication at this
locus had been reported in literature or described in
Fig. 1 The proband at 2 years 2 months of age. Note scaphocephaly
and flat facial profile, auricle dysplasia, low-set and asymmetrical ears,
small eyes, flat nose bridge, shallow philtrum, small and open mouth,
teeth dysplasia, micrognathia, sparse eyebrows and hair, short hands
and broad fingers
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database. We identified several cases with duplications of
ZEB2 gene in DECIPHER and ISCA databases (Table 2
and Fig. 3). All these duplications were de novo except for
ones without parental tests and no copy number gain in-
cluding ZEB2 gene was reported in the DGV, which
strongly suggested a pathogenic nature of these copy
number gains.
There are four genes involved in the copy number gain
at 2q22.3 of our patient: ZEB2, GTDC1 and TEX41
genes are triplicated, part of ARHGAP15 is duplicated.
ARHGAP15, a member of the RHO GTPase-activating
proteins (GAPs), regulates RHO GTPases (see ARHA;
MIM 165390) which regulates diverse biologic processes
[15]. GTDC1 is ubiquitous expressed at relatively high
levels in lung, spleen, testis, and peripheral blood leuko-
cytes, suggesting that it may have biochemical functions
in these organs [16]. TEX41 is a non-protein coding
gene. Currently, none of the three genes are known to
have any clinical significance.
The protein encoded by ZEB2 gene is a member of
δEF1/Zfh-1 family, containing a Smad-binding do-
main, a homeodomain-like sequence, and two separ-
ate clusters of zinc fingers at the amino and carboxy
terminals [17]. The ZEB2 protein interacts with
SMAD proteins and acts as a transcriptional repressor
in response to TGF-β signaling [17]. The SMAD pro-
teins are cytoplasmic mediators that are tightly con-
trolled and play an important role in relaying TGF-ß
signals from cell-surface receptors to the nucleus. The
TGF-ß family exerts a wide range of biological func-
tions in cell growth, differentiation, apoptosis and de-
velopment of the embryo. ZEB2 gene is highly
conserved among different species. The homologous
alignment at amino acid levels reveals 97 % similar-
ities between human and mouse, and 88 % between
human and Xenopuslaevis. In addition, these proteins
share the same amino acids in the zinc finger domain
and certain similarities in their Smad binding domain
(SBD). These findings suggest that the protein plays a
similar role in vivo.
It was important to note that overexpression of Xen-
opus SIP1 (XSIP1) induced enlargement of neural tissue
in anterior region, and some embryos failed to form eye
vesicles and normal head phenotypes. Ectopic expression
of XSIP1 induced anterior neural markers suggesting
that XSIP1 played a role in early neurogenesis [18]. The
animal model evidence shows that the ZEB2 gene is dos-
age sensitive and its precise regulation and expression is
vital to embryonic neural and neural crest development.
Currently several genes have been known to be dosage
sensitive genes, such as MECP2, NIPBL and NSD1 etc.
For example, it is well known that haploinsufficiency of
MECP2 gene typically results in Rett syndrome in fe-
males and severe neonatal encephalopathy or lethality in
males [19]. Duplications overlapping the entire MECP2
gene are associated with MECP2 duplication syndrome
Fig 2 Affymetrix cytoscan HD array analysis including weighted log2 ratio (upper), copy number state (middle) and allele peaks (lower) are shown
for chromosome 2. The result shows copy number gain at 2q22.2q22.3 encompassing the entire ZEB2 gene. The genomic coordinates (hg19):
chr2: 143,886,436-146,831,592. The copy number gain region is denoted by a black bar
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characterized by global developmental delay, intellectual
disability, autistic features, epilepsy and recurrent infec-
tions [20]. Patients with MECP2 triplications have also
been reported with more severe phenotypes [21]. Corne-
lia de Lange syndrome is a multisystem congenital
anomaly disorder and mutations or deletions of NIPBL
gene is a major cause for this condition [22]. Conversely,
NIPBL copy number gain is responsible for 5p13 dupli-
cation syndrome consisting of developmental delay,
learning disability, distinctive facial features and behavior
problems [23–25]. Similarly, haploinsufficiency of the
NSD1 gene located on 5q35 is the major cause of
Sotos syndrome recognized by intellectual disability, over-
growth, typical facial appearance, behavior problems and
seizures [26], whereas reciprocal duplications of Sotos
syndrome region overlapping the entire NSD1 gene
present a reverse phenotype including delayed bone age,
microcephaly, developmental delay and seizures [27, 28].
We believe more dosage sensitive genes exist in the
human genome and are yet to be discovered. Here we pro-
vide the first evidence suggesting that ZEB2 gene is such a
dosage sensitive gene similar to the aforementioned genes.
In conclusion, we first report a patient carrying a tripli-
cation at 2q22.3 involving the entire ZEB2 gene who pre-
sents overlapping features of Mowat-Wilson syndrome.
Based on the clinical evidence from patients with de novo
copy number gain involving the ZEB2 gene and the ex-
perimental evidence from Xenopus ZEB2 overexpression
Table 1 Comparison of the clinical features of Mowat-Wilson syndrome and our patient with 2q22.3 triplication involving ZEB2 gene
Features of MWS Features of our patient
craniofacial features
▷ craniosynostosis craniosynostosis-scaphocephaly
▷ frontal bossing -
▷ microcephaly microcephaly at birth, normal at 2 years 2 months
▷ deep-set large and widely spaced eyes - (small eyes)
▷ large uplifted earlobes with a dimple in the middle auricle dysplasia, low-set and asymmetrical
▷ a saddle nose with a rounded nasal tip - (flat nose bridge)
▷ open mouth appearance +
▷ M-shaped upper lip -
▷ prominent but narrow chin - (micrognathia)
▷ large, flaring eyebrows - (sparse eyebrows and hair)
▷ elongated face - (flat facial profile)
moderate to severe intellectual disability mild cognitive impairment
developmental delay
▷ growth development +
▷ delayed motor development +
▷ severe speech impairment with relative preservation of receptive language +
short stature IUGR with postnatal catch-up
hypotonia +
heart defects + (small atrial septal defect)
corpus callosum agenesis -
epilepsy -
hirschsprung disease - (mild to moderate constipation)
friendly and happy personalities +
abnormalities of the urinary tract and genitalia + (small testes)
hypospadias -
eye defects -
hand anomalies + (short hands and broad fingers)
others (skin pigmentary changes, etc.) -
+ feature present; − feature absent
Yuan et al. Molecular Cytogenetics  (2015) 8:99 Page 4 of 7
Table 2 Genomic and clinical information of patients with duplication or triplication involving ZEB2 gene
Patients Our patient Decipher
305834
Decipher 248386 Decipher 251363 Decipher 260771 ISCA ISCA ISCA
nssv578831 nssv581021 nssv582319
nssv582654
Genomic location (hg19) chr2:143886436 chr2:143871597 chr2:144872516 chr2:143289932 chr2:139199740 chr2:145219415 chr2:144657717 chr2:144657717
−146831592 −146250048 −151071321 −151513175 −151305504 −145422833 −145425705 −159178136
Size 2.9 Mb 2.4 Mb 6.2 Mb 8.2 Mb 12.1 Mb 203Kb 768Kb 14.5 Mb
triplication duplication duplication duplication duplication duplication duplication duplication
Inheritance De novo unknown De novo De novo De novo De novo unknown unknown
Phenotype ID, DD, MCA,
Behavior
problems
ID Hearing impairment ID, distinctive facial
features, cryptorchidism,
macrodontia
ID seizure DD, MCA and
autism
GDD
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model, we propose that ZEB2 copy number gain is func-
tionally and clinically significant.
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